Related Experiment Videos
Transcultural diabetes nutrition therapy algorithm: the Asian Indian application
Shashank R Joshi1, V Mohan, S S Joshi
1Department of Endocrinology Grant Medical College and Sir J J Group of Hospitals, Lilavati Hospital, Bhatia Hospital, Joshi Clinic, Bandra Reclamation, Bandra West, Mumbai, India. Shashank.sr@gmail.com
Current Diabetes Reports
|February 23, 2012
Summary
A new transcultural Diabetes Nutrition Algorithm (tDNA) was developed and customized for India to manage type 2 diabetes (T2D) and cardiovascular disease epidemics. This India-specific tDNA offers a structured approach, improving metabolic control and weight loss in diverse populations.
Area of Science:
- Endocrinology and Metabolism
- Public Health Nutrition
- Cardiovascular Disease Epidemiology
Background:
- Asia, particularly India, faces escalating epidemics of type 2 diabetes (T2D) and cardiovascular disease.
- Rapid demographic, socioeconomic, and nutritional shifts contribute to rising noncommunicable diseases.
- Existing clinical practice guidelines (CPGs) lack cultural portability, limiting their effectiveness in diverse regions.
Purpose of the Study:
- To develop and customize a transcultural Diabetes Nutrition Algorithm (tDNA) for India.
- To address the limitations of current CPGs in the Indian context.
- To provide a culturally relevant tool for managing T2D and cardiovascular disease.
Main Methods:
- Development of a transcultural Diabetes Nutrition Algorithm (tDNA).
- Customization of the tDNA based on India's unique epidemiologic, physiologic, and nutritional characteristics.
- Consideration of socioeconomic factors, body composition, lifestyle, and cultural practices.
Main Results:
- An India-specific tDNA was created, reflecting regional variations.
- The tDNA incorporates unique factors like transitional economy, body fat percentage, sedentary lifestyle, thrifty phenotype, and cultural events.
- The algorithm aims to guide physicians in managing prediabetes and T2D more effectively.
Conclusions:
- The India-specific tDNA offers a culturally adapted and systematic approach to managing T2D and cardiovascular disease.
- This tool addresses the limitations of generic CPGs in the Indian subcontinent.
- It integrates political, policy, and governmental factors for a holistic management strategy.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...